Variant report
Variant | nsv891330 |
---|---|
Chromosome Location | chr8:113942738-114009227 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:113948637..113951504-chr8:113954981..113956955,2 | K562 | blood: | |
2 | chr8:113982822..113985286-chr8:113988301..113991083,2 | K562 | blood: | |
3 | chr8:113982822..113985286-chr8:113988301..113991083,2 | K562 | blood: | |
4 | chr8:113948637..113951504-chr8:113954981..113956955,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539265998 | chr8:113950828-113950829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556280164 | chr8:113950849-113950850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576157002 | chr8:113950868-113950869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188225107 | chr8:113950886-113950887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147867369 | chr8:113950897-113950898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561856634 | chr8:113950930-113950931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13280853 | chr8:113950999-113951000 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs79818074 | chr8:113951006-113951007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564183396 | chr8:113951009-113951010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577623280 | chr8:113951011-113951012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529123094 | chr8:113951013-113951014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546083352 | chr8:113951058-113951059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563143136 | chr8:113951072-113951073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531801430 | chr8:113951085-113951086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548501499 | chr8:113951103-113951104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562016917 | chr8:113951117-113951118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527695387 | chr8:113951132-113951133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78427053 | chr8:113951134-113951135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562767540 | chr8:113951152-113951153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570617555 | chr8:113951181-113951182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376641203 | chr8:113951196-113951197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191934097 | chr8:113951218-113951219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569867917 | chr8:113951239-113951240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11991413 | chr8:113951265-113951266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs62514564 | chr8:113951274-113951275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566717714 | chr8:113951374-113951375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147050507 | chr8:113951391-113951392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533860817 | chr8:113951412-113951413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557738682 | chr8:113951459-113951460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370031994 | chr8:113951464-113951465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531295698 | chr8:113951479-113951480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73702262 | chr8:113951481-113951482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543543086 | chr8:113951485-113951486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147692827 | chr8:113951509-113951510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576599655 | chr8:113951553-113951554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541986034 | chr8:113951589-113951590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76351221 | chr8:113951655-113951656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527933079 | chr8:113951684-113951685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571313991 | chr8:113951744-113951745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35055241 | chr8:113951757-113951758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149175932 | chr8:113951766-113951767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527394722 | chr8:113951768-113951769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533160848 | chr8:113951790-113951791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190660186 | chr8:113975404-113975405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530002158 | chr8:113975416-113975417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7007990 | chr8:113975465-113975466 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs544299411 | chr8:113975467-113975468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557861473 | chr8:113975474-113975475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577753655 | chr8:113975479-113975480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs72682180 | chr8:113975485-113975486 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Prostate cancer | 22341455 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:113950800-113951400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr8:113950800-113951400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr8:113950800-113951800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr8:113951000-113951600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr8:113975400-113975800 | Enhancers | Hela-S3 | cervix |
6 | chr8:113976800-113977600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr8:113977000-113977600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr8:113983200-113983600 | Enhancers | Fetal Intestine Small | intestine |
9 | chr8:113988000-113988400 | Active TSS | Hela-S3 | cervix |
10 | chr8:113988000-113988600 | Enhancers | Fetal Brain Male | brain |
11 | chr8:113994400-113997000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr8:113994600-113994800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr8:113994600-113995000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr8:113994600-113995000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr8:113994800-113995800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr8:113995000-113995400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
17 | chr8:113995000-113996000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr8:113995400-113996000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr8:113995800-113996200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr8:113996000-113996200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |